134 related articles for article (PubMed ID: 2453881)
21. D6.1, a murine antimelanoma monoclonal antibody from congenitally athymic nude mice immunized with purified melanoma tumor-associated antigen.
Stuhlmiller GM; Borowitz MJ; Seigler HF
Hybridoma; 1984; 3(4):333-46. PubMed ID: 6396196
[TBL] [Abstract][Full Text] [Related]
22. Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms.
Woodbury RG; Brown JP; Yeh MY; Hellström I; Hellström KE
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2183-7. PubMed ID: 6929544
[TBL] [Abstract][Full Text] [Related]
23. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
Kimmel KA; Carey TE; Judd WJ; McClatchey KD
J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens.
Kantor RR; Ng AK; Giacomini P; Ferrone S
Hybridoma; 1982; 1(4):473-82. PubMed ID: 6208142
[TBL] [Abstract][Full Text] [Related]
26. A 94,000-dalton glycoprotein expressed by human melanoma and carcinoma cells.
Imai K; Wilson BS; Bigotti A; Natali PG; Ferrone S
J Natl Cancer Inst; 1982 May; 68(5):761-9. PubMed ID: 6951087
[TBL] [Abstract][Full Text] [Related]
27. Unique epitopes of common acute lymphoblastic leukemia antigen detected by new monoclonal antibodies.
Matsuzaki H; Haruta Y; Fukukawa T; Barcos MP; Seon BK
Cancer Res; 1987 Apr; 47(8):2160-6. PubMed ID: 2435407
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies to the large glycoproteins of respiratory syncytial virus: possible evidence for several functional antigenic sites.
Tsutsumi H; Flanagan TD; Ogra PL
J Gen Virol; 1987 Aug; 68 ( Pt 8)():2161-7. PubMed ID: 2440982
[TBL] [Abstract][Full Text] [Related]
29. Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line.
Mirski SE; Cole SP
Cancer Res; 1989 Oct; 49(20):5719-24. PubMed ID: 2571409
[TBL] [Abstract][Full Text] [Related]
30. Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Mattes MJ; Cordon-Cardo C; Lewis JL; Old LJ; Lloyd KO
Proc Natl Acad Sci U S A; 1984 Jan; 81(2):568-72. PubMed ID: 6582512
[TBL] [Abstract][Full Text] [Related]
31. Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systems.
Garin-Chesa P; Beresford HR; Carrato-Mena A; Oettgen HF; Old LJ; Melamed MR; Rettig WJ
Am J Pathol; 1989 Feb; 134(2):295-303. PubMed ID: 2916650
[TBL] [Abstract][Full Text] [Related]
32. Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Shockley TR; Lin K; Nagy JA; Tompkins RG; Yarmush ML; Dvorak HF
Cancer Res; 1992 Jan; 52(2):367-76. PubMed ID: 1728408
[TBL] [Abstract][Full Text] [Related]
33. Murine monoclonal anti-idiotope antibody breaks unresponsiveness and induces a specific antibody response to human melanoma-associated proteoglycan antigen in cynomolgus monkeys.
Chattopadhyay P; Starkey J; Morrow WJ; Raychaudhuri S
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2684-8. PubMed ID: 1557374
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
35. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
36. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.
Seeger RC; Rosenblatt HM; Imai K; Ferrone S
Cancer Res; 1981 Jul; 41(7):2714-7. PubMed ID: 6166367
[TBL] [Abstract][Full Text] [Related]
37. Cell-cell adherence as a selection method for the generation of anti-melanoma monoclonal antibodies.
Barral AM; Fernández A; Faxas ME; Pérez X; García CA; Rosén A
J Immunol Methods; 1997 Apr; 203(1):103-9. PubMed ID: 9134034
[TBL] [Abstract][Full Text] [Related]
38. Serological responses of melanoma patients to vaccines derived from allogeneic cultured melanoma cells.
Livingston PO; Takeyama H; Pollack MS; Houghton AN; Albino A; Pinsky CM; Oettgen HF; Old LJ
Int J Cancer; 1983 May; 31(5):567-75. PubMed ID: 6852975
[TBL] [Abstract][Full Text] [Related]
39. Human monoclonal antibodies directed against melanoma tumor-associated antigens.
Kan-Mitchell J; Imam A; Kempf RA; Taylor CR; Mitchell MS
Cancer Res; 1986 May; 46(5):2490-6. PubMed ID: 3697990
[TBL] [Abstract][Full Text] [Related]
40. Human melanoma-associated antigens: analysis of antigenic heterogeneity by molecular, serologic and flow-cytometric approaches.
Morgan AC; Woodhouse C; Bartholemew R; Schroff R
Mol Immunol; 1986 Feb; 23(2):193-200. PubMed ID: 2422545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
